| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9273796 | Transplant Immunology | 2005 | 11 Pages |
Abstract
These finding leads us to the conclusion that the ABO compatibility is not a disadvantage in BMT, whereas the delayed recovery of neutrophils in patients having received an ABO mismatched graft is probably reflecting a transient humoral process leading to immune tolerance and graft accommodation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Primož Rožman, Andrej Košir, Mateja Bohinjec,